Endpoint Health
Private Company
Total funding raised: $60M
Overview
Endpoint Health is an early-stage, private biotech leveraging AI and diagnostics to advance precision medicine. Founded in 2020 and headquartered in Palo Alto's vibrant life sciences hub, the company is positioned in a high-growth sector but maintains a low public profile with minimal operational details available. Its stated focus on using AI to analyze data and optimize experiences suggests a platform-based approach to clinical decision support or diagnostic development, though its pipeline and business model remain undefined due to limited public information.
Technology Platform
Inferred to be an AI/ML platform applied to diagnostic data for precision medicine, but not publicly detailed.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
The competitive field is crowded with both large, established diagnostic companies (e.g., Roche, Abbott, Quest) investing heavily in AI, and numerous well-funded pure-play AI-healthcare startups (e.g., Tempus, Paige.AI, PathAI). Endpoint Health's differentiation, if any, is not currently apparent from public materials.